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Abstract
TET proteins oxidize 5-methylcytosine in DNA to 5-hydroxymethylcytosine and other oxidation 
products. We found that simultaneous deletion of Tet2 and Tet3 in mouse CD4+CD8+ double-
positive thymocytes resulted in dysregulated development and proliferation of invariant natural 
killer T cells (iNKT cells). Tet2-Tet3 double-knockout (DKO) iNKT cells displayed pronounced 
skewing toward the NKT17 lineage, with increased DNA methylation and impaired expression of 
genes encoding the key lineage-specifying factors T-bet and ThPOK. Transfer of purified Tet2-
Tet3 DKO iNKT cells into immunocompetent recipient mice resulted in an uncontrolled expansion 
that was dependent on the nonclassical major histocompatibility complex (MHC) protein CD1d, 
which presents lipid antigens to iNKT cells. Our data indicate that TET proteins regulate iNKT 
cell fate by ensuring their proper development and maturation and by suppressing aberrant 
proliferation mediated by the T cell antigen receptor (TCR).
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T cell development is tightly regulated by transcription factors that dictate lineage 
commitment1,2. The DNA-binding transcription factors Foxp3, Runx3, ThPOK and PLZF 
orchestrate the cell-specific transcriptional programs of regulatory T cells (Treg cells), CD8+ 
single-positive (CD8SP) T cells, CD4+ single-positive (CD4SP) T cells and iNKT cells, 
respectively2,3. Transcription factors also control the further differentiation of peripheral 
naive CD4+ T cells into the TH1 subset of helper T cells that expresses the transcription 
factor T-bet, TH2 cells that express the transcription factor GATA-3 and TH17 cells that 
express the transcription factor RORγt4.
Whereas conventional T cells are selected by peptide antigens presented on MHC class I and 
II proteins, iNKT cells are positively selected in the thymus through recognition of lipid 
antigens presented by the nonclassical MHC-class-I-like protein CD1d3, and their 
differentiation is induced by strong TCR signaling through agonist selection5. iNKT cells 
are defined by their ability to bind CD1d–α-galactosyl-ceramide tetramers (called simply 
‘tetramers’ here) and are subdivided into four stages on the basis of their expression of 
surface markers: stage 0 iNKT precursors have high expression of the B cell–differentiation 
marker CD24; stage 1 cells have undergone positive selection and massive proliferation and 
downregulate CD24 expression; stage 2 cells continue proliferating and upregulate 
expression of the activation and memory marker CD44, but do not express the activating NK 
cell receptor NK1.1; and stage 3 cells are CD44+NK1.1+ (ref. 3).
An alternative transcription-factor-centered classification categorizes iNKT cells that 
express T-bet and secrete interferon-γ (IFN-γ) as NKT1 cells; iNKT cells that express 
GATA-3 and secrete mostly interleukin 4 (IL-4) as NKT2 cells; and iNKT cells that express 
RORγt and produce IL-17 as NKT17 cells (ref. 6). Phenotypically, NKT1 cells are 
PLZFloNK1.1+ and have been described as ‘stage 3′ cells3, whereas NKT2 and NKT17 
cells are characterized by the lack of NK1.1 expression3 and therefore fall into stage 2 of 
iNKT cell development. These three lineages are distinct, as they do not interconvert when 
they are injected intrathymically6.
Gene expression is subject to epigenetic regulation by histone and DNA modifications, 
nucleosome positioning, chromatin remodeling, and long-range chromatin interactions, 
which collectively affect the binding of transcription factors to their consensus sequences in 
DNA7,8. Among the most recently discovered epigenetic modifiers are the TET-family 
dioxygenases TET1, TET2 and TET3, which catalyze the oxidation of 5-methylcytosine 
(5mC) in DNA to 5-hydroxymethylcytosine (5hmC) and other oxidation products9–11. These 
modified bases are intermediates in DNA demethylation as well as epigenetic marks that 
may recruit specific readers12.
Dynamic changes in the distribution of 5hmC during thymic T cell lineage specification 
have been reported13. Here we found that deletion of both Tet2 and Tet3 in mice resulted in 
a lethal lymphoproliferative disease characterized by massive antigen-dependent expansion 
of iNKT cells. The disease was recapitulated by the transfer of small numbers of highly 
purified Tet2-Tet3 DKO iNKT cells into fully immunocompetent wild-type recipient mice, 
but could not be recapitulated by the transfer of such cells into CD1d-deficient recipient 
mice, which indicated that the iNKT cell expansion was driven by antigen recognition and 
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TCR signaling. In parallel, we observed a pronounced skewing toward the NKT17 lineage, 
which correlated with increased DNA methylation and decreased expression of lineage-
specifying transcription factors such as T-bet and ThPOK. Overall, our data indicate that 
TET2 and TET3 are important regulators of iNKT cell development and lineage 
specification, as well as tumor suppressors that restrict TCR-driven expansion.
RESULTS
iNKT cell expansion in Tet2-Tet3 DKO mice
TET2 and TET3 are the main TET proteins expressed in mouse T cells14. Tet2−/− mice15 are 
healthy and show no defects in T cell development, but Tet3−/− mice display perinatal 
death16. To evaluate the effect of deletion of both Tet2 and Tet3, we crossed Tet3fl/flCd4-Cre 
(Tet3 KO) mice (in which loxP-flanked Tet3 alleles (Tet3fl/fl) are deleted by Cre 
recombinase expressed from the T cell–specific Cd4 promoter (Cd4-Cre)) with Tet2−/− mice. 
Deletion of the Tet2 and Tet3 exons in T cells was confirmed by quantitative PCR; there was 
no compensatory upregulation of Tet1 mRNA (Supplementary Fig. 1a). Global 5hmC 
content was considerably lower, but was not eliminated, in sorted double-positive (DP), 
CD4SP and CD8SP thymocytes of Tet2−/− Tet3fl/flCd4-Cre (Tet2-Tet3 DKO mice) than in 
the corresponding subsets of wild-type mice (Supplementary Fig. 1b). Although most of our 
experiments were performed with Tet2−/−Tet3fl/flCd4-Cre mice, we observed identical 
phenotypes in Tet2fl/flTet3fl/flCd4-Cre mice (data not shown).
Beginning at 5 weeks of age, all Tet2-Tet3 DKO mice lost weight and exhibited a bloated 
and hunched appearance, whereas Tet2−/− and Tet3 KO mice remained healthy up to 14 
months (data not shown). Within a few weeks of birth, Tet2-Tet3 DKO mice developed 
enlarged spleens and lymph nodes (data not shown), with disrupted architecture and loss of 
germinal centers (Supplementary Fig. 1c). The lungs and livers of Tet2-Tet3 DKO mice 
showed pronounced lymphocyte infiltration (Supplementary Fig. 1c). By 5–7 weeks, spleen 
cellularity was substantially increased (Fig. 1a), and all of the mice succumbed by 8 weeks 
of age (Fig. 1b). Disease development was associated with a massive expansion of iNKT 
cells in spleen and lymph nodes, even in young mice that maintained a normal reservoir of 
Treg cells (Fig. 1c,d); single deletion of Tet2 or Tet3 had a small, but significant, effect (Fig. 
1e,f and Supplementary Fig. 1d,e). Moreover, compared with their wild-type counterparts, 
3–4-week-old Tet2-Tet3 DKO mice showed decreased thymic cellularity and decreased 
percentages and numbers of DP thymocytes, suggestive of intrathymic stress, as well as a 
relative increase in the number and frequency of CD4SP and CD8SP cells in the thymus 
(Supplementary Fig. 2a–d). In contrast, peripheral lymphoid organs (spleen and lymph 
nodes) showed greatly increased cellularity despite decreased frequencies of peripheral 
CD4+ and CD8+ T cells (Supplementary Fig. 2e–h). Overall, simultaneous loss of Tet2 and 
Tet3 resulted in iNKT cell expansion and lethal disease.
Regulation of iNKT-cell-lineage specification by TET2 and TET3
Notably, the selective expansion of Tet2-Tet3 DKO iNKT cells was already apparent in the 
thymus of very young (20-day-old) Tet2-Tet3 DKO mice (Fig. 2a–c). The percentages and 
absolute numbers of thymic iNKT cells were much greater in Tet2-Tet3 DKO mice than in 
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wild-type, Tet2−/− or Tet3 KO mice (Supplementary Fig. 3a,b). Compared with iNKT cells 
of the other genotypes, Tet2-Tet3 DKO iNKT cells showed increased expression of RORγt 
in the thymus and periphery and loss of CD4 expression, which suggested skewing toward 
an NKT17-like phenotype6; decreased expression of Tbet in the thymus, which reflected a 
decrease in the number of NKT1-lineage cells; and increased expression of PLZF, consistent 
with a reduction in the number of cells of the NKT1 cell (PLZFlo) lineage (Fig. 2d,e and 
Supplementary Fig. 3). In wild-type mice, more than 60% of iNKT cells were NKT1 cells, 
whereas the predominant NKT cell subtype in Tet2-Tet3 DKO mice was NKT17 (Fig. 2f). 
However, because of the prominent iNKT cell expansion in the thymus, all effector iNKT 
cell subtypes were overrepresented in thymocytes of Tet2-Tet3 DKO relative to their 
abundance in wild-type mice (Fig. 2g).
Consistent with their skewing toward the NKT17 cell lineage, Tet2-Tet3 DKO iNKT cells 
potently produced IL-17 when stimulated with phorbol 12-myristate 13-acetate (PMA) and 
ionomycin (Supplementary Fig. 4a–c). The frequency of IFN-γ-producing iNKT cells was 
diminished relative to wild type, but, as a result of the iNKT cell expansion, the percentage 
of IFN-γ-producing iNKT cells among total thymocytes was increased (Supplementary Fig. 
4d–f). This was also observed for IL-4 (Supplementary Fig. 4g–i). Relative to wild type, the 
increased numbers of PLZFhi, IL-4 producing iNKT cells in Tet2-Tet3 DKO mice were 
associated with the expected increase in numbers of innate-like memory CD8SP cells17 
(Supplementary Fig. 4j,k), which showed high expression of genes associated with an 
activated, memory-like phenotype (data not shown). Tet2-Tet3 DKO CD8+ cells were 
underrepresented in the periphery (Supplementary Fig. 2e–h), presumably as a result of 
defects in migration and/or survival. We focused on the aberrant iNKT cells in Tet2-Tet3 
DKO mice.
TetramerhiNK1.1− cells, which normally include CD4+CD27+ NKT2 cells6, NKT17 cells 
that do not express CD4 (ref. 6) and NKT1 precursor cells identified by T-bet expression18, 
were greater in terms of both percentage and absolute numbers in Tet2-Tet3 DKO mice than 
in wild-type mice (Fig. 2h–j). CD4 expression was almost undetectable in Tet2-Tet3 DKO 
iNKT cells, in contrast to its detectable expression in wild-type iNKT cells (Fig. 2h and 
Supplementary Fig. 3c). There was also a much larger PLZF+RORγt+ population in the 
NK1.1− Tet2-Tet3 DKO subset than in its wild-type counterpart (Supplementary Fig. 5a,b), 
with a concomitant decrease in the PLZF+T-bet+ subset that is thought to contain precursors 
of NKT1-cell-lineage cells (Supplementary Fig. 5c,d). Compared with their wild-type 
counterparts, a small population of Tet2-Tet3 DKO tetramer+NK1.1+CCR6−CD27+ NKT1 
cells exhibited higher expression of PLZF than that of their their wild-type counterparts and 
aberrant expression of RORγt, and a small fraction of this PLZFhi population did not 
express T-bet (Supplementary Fig. 5e). The NK1.1+ Tet2-Tet3 DKO iNKT cells were not 
only less frequent among the thymic iNKT cells than their wild-type counterparts, but they 
were also functionally compromised, as they produced less IFN-γ than did wild-type cells 
(Supplementary Fig. 5f,g). We concluded that Tet2 and Tet3 regulated the generation and 
maturation of these iNKT cell lineages.
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NKT17 lineage skewing in Tet2-Tet3 DKO iNKT cells
Transcriptional profiling of total thymic iNKT cells confirmed skewing toward the NKT17 
cell lineage, with iNKT cells from young (3- to 4-week-old) Tet2-Tet3 DKO mice showing 
higher expression of Il17f, Rorc (which encodes RORγt) and Eomes and lower expression 
of Ifng, Il4, Tbx21 (which encodes T-bet) and Zbtb7b (which encodes ThPOK) than wild-
type iNKT cells (Fig. 3a,b). We also observed higher expression of Lef1, which can promote 
malignant transformation19; Rag1, whose expression in NK cells correlates with an 
enhanced fitness, proliferative and survival capacity20; and the oncogenes Lmo4 (ref. 21) 
and Myb22 (Fig. 3a). These genes normally have high expression in DP thymocytes and are 
progressively downregulated1, which indicates that Tet2-Tet3 deficiency results in 
developmental immaturity.
We also compared subtypes of wild-type and Tet2-Tet3 DKO iNKT cells (Fig. 3c). Genes 
that were downregulated in Tet2-Tet3 DKO stage 0 iNKT precursors relative to their 
expression in wild-type cells included those encoding CD4, Bcl11b (which restricts the 
NKT17 lineage23) and Satb1 (which forms complexes with PLZF in the presence of the 
Cullin E3 ligase24); genes that were upregulated included Zbtb16 (which encodes PLZF) 
and Lmo4 (Fig. 3c). In the heterogeneous NK1.1− iNKT cell population, genes that were 
upregulated in Tet2-Tet3 DKO cells relative to their expression in wild-type cells included 
Rorc, Zbtb16 and Myc (whose product controls iNKT cell proliferation25), and genes that 
were downregulated included Cd4, Satb1, Tbx21 and Zbtb7b (Fig. 3c). Combined loss of 
Tet2 and Tet3 affected the number, maturation and identity of the generated NKT1 cells; 
among the upregulated genes that we identified, Rorc and Lef1 (which is usually 
upregulated at an earlier stage (stage 0) of iNKT cell development)18 were expressed in 
stage 1 and 2 iNKT cells but are normally absent in stage 3 iNKT cells26. Thus, TET2 and 
TET3 markedly affect the gene-expression profiles of all iNKT cell subsets.
Enhanced proliferation of Tet2-Tet3 DKO iNKT cells
The upregulation of Myc, Rag1, Lmo4, Myb and other genes associated with the iNKT 
precursor state and high proliferative capacity prompted us to assess the proliferation of 
Tet2-Tet3 DKO iNKT cells in vivo. We injected mice with BrdU, a thymidine analog that is 
incorporated into DNA during replication, and analyzed iNKT cells 16 h later. Indeed, Tet2-
Tet3 DKO iNKT cells showed significantly higher BrdU incorporation than did wild-type 
thymic iNKT cells (Fig. 3d,e).
Given that Treg cell function is compromised in Tet2-Tet3 DKO mice27, we sought to 
determine whether uncontrolled iNKT cell expansion would occur in the presence of intact 
Treg cells and, if so, whether antigen recognition would be involved. We transferred total 
Tet2-Tet3 DKO splenocytes (data not shown) or purified Tet2-Tet3 DKO iNKT cells (5 × 
105) into fully immunocompetent (non-irradiated) CD45.1+ recipient mice, either wild-type 
or lacking CD1d. All wild-type recipients developed enlarged spleen and lymph nodes and 
succumbed to disease by 90 d, whereas all CD1d-deficient (CD1d KO) recipients remained 
healthy (Fig. 4a). Spleen and lymph node cellularity increased significantly in the recipient 
mice, to an average of ~5 × 108 cells after transfer (Fig. 4b); of these, typically >80% were 
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iNKT cells (Fig. 4c). We also observed a slight expansion in CD1d KO recipients (Fig. 
4b,c).
Compared with the expression of these genes in wild-type iNKT cells (Fig. 4d), transferred 
Tet2-Tet3 DKO iNKT cells maintained their expression of Rorc and Myb, upregulated their 
expression of genes encoding transcriptional regulators and oncogenic factors indicative of 
earlier stages of T cell development (Lmo1 and Lmo2 (ref. 21), Tcf7 and Myc28,29), as well 
as genes such as Ret30, whose products improve hematopoietic stem cell expansion and 
transplantation efficiency (Fig. 4d,e). Pathway-enrichment analysis revealed two main 
categories of differentially expressed genes: those encoding products related to T cell 
function and those encoding products related to DNA replication, cell cycle and DNA 
damage repair (Fig. 4f). Together these data indicated that loss of function of TET proteins 
conferred a cell-intrinsic phenotype of uncontrolled iNKT cell proliferation that was driven 
by antigen recognition and could be observed in recipient mice with normal immunological 
and Treg cell function.
TET2 and TET3 regulate chromatin accessibility
5hmC mapping by immunoprecipitation of DNA fragments containing cytosine-5-
methylenesulfonate, the product of the reaction of 5hmC with sodium bisulfite (CMS-
IP)31,32. revealed that the greatest amounts of 5hmC in wild-type iNKT cells were present in 
the gene bodies of the genes with the highest expression (Fig. 5a,b), as has been shown for 
other T cell types13. Whole-genome bisulfite sequencing (WGBS) of wild-type iNKT cells 
confirmed the expected inverse correlation between gene expression and DNA modification 
(5mC+5hmC) at promoters and transcription start sites (TSS)33 and revealed that loss of 
5mC+5hmC extended deeply into the gene bodies of the genes with the greatest 
transcription (Fig. 5c). Relative to the abundance of 5mC and/or 5hmC at enhancers 
identified in embryonic stem cells or in cardiac tissue, thymus-specific enhancers34 showed 
greater enrichment for 5hmC13 (472 of 5,605 thymic enhancers intersect with 5hmC; Fig. 
5d). Their and their 5mC+5hmC content was greater in Tet2-Tet3 DKO iNKT cells than in 
wild-type iNKT cells (Fig. 5e). Our data indicated that TET proteins were needed 
continuously to constrain CpG methylation of these enhancers in iNKT cells.
Comparing wild-type and young Tet2-Tet3 DKO iNKT cells, we found a much greater 
average abundance of 5mC+5hmC at the TSS and in gene bodies of Tet2-Tet3 DKO iNKT 
cells than in those of wild-type cells, whether we considered all genes (data not shown) or 
only differentially expressed genes (Supplementary Fig. 6a). The increase was specific, as it 
was not seen in randomly chosen genome fragments of similar size (Supplementary Fig. 6a). 
Both upregulated genes and downregulated genes in Tet2-Tet3 DKO iNKT cells showed 
similar increases 5mC+5hmC at promoters and TSSs, as well as gene-body modifications 
(Supplementary Fig. 6b). Similar findings have been reported for Tet2-Tet3 DKO 
hematopoietic stem cells and precursor cells35. Overall, although it was clear that TET 
proteins regulated DNA modification in transcribed regions of the genome (promoters, gene 
bodies and enhancers), our data suggested a complex relationship between loss of TET 
protein function, the resulting increase in DNA methylation and changes in gene expression.
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Nevertheless, our data suggested involvement of TET proteins in developmental transitions 
in lymphocytes. Comparing our WGBS data for wild-type iNKT cells with data for common 
lymphoid progenitor (CLP) cells36, we identified differentially methylated regions (DMRs) 
whose modification status changed during the differentiation of CLP cells into iNKT cells 
(Fig. 6a). 2,100 regions gained 5mC+5hmC and 1,400 DMRs lost 5mC+5hmC. Focusing on 
differentiation-related DMRs that lost 5mC+5hmC during the CLP–to–iNKT cell transition, 
we found that Tet2-Tet3 DKO iNKT cells showed increased modification at these DMRs 
(Fig. 6a), which indicated that loss of 5mC+5hmC during the CLP–to–iNKT cell transition 
required TET2 and TET3. Even in regions that gained modification as CLPs differentiated 
into iNKT cells, DNA modification increased further in Tet2-Tet3 DKO iNKT cells (Fig. 
6a), which suggested that cytosine methylation by DNA methyltransferases at these regions 
was unhindered in the absence of TET2 and TET3. All three TET proteins had higher 
expression in iNKT cells than in CLP cells37 (Fig. 6b).
We compared the genome-wide distribution of all DMRs with that of 5hmC. Two thirds of 
all DMRs, whether more highly modified in Tet2-Tet3 DKO iNKT cells or in wild-type 
iNKT cells, were located distal to promoter-TSS regions (that is, more than 5 kb from the 
TSS; Fig. 6c). Of a total of 10,945 DMRs (Table 1) that were more methylated (5mC
+5hmC) in Tet2-Tet3 DKO iNKT cells than in wild-type cells, ~42% overlapped with 
regions that contained 5hmC in wild-type iNKT cells; of these, ~32% were near TSSs (±5 
kb), corresponding to a total of 1,270 genes (Table 1). Only 183 (~14%) of these genes 
showed altered expression (Table 1). These results supported the idea that a subset of 5hmC-
bearing promoters in wild-type cells acquire more 5mC+5hmC in the absence of TET 
function and that a small fraction of the corresponding genes show the expected correlation 
between increased promoter methylation and decreased expression. A caveat for this is that 
part, or all, of the modification that we measured might have been a result of 5hmC 
deposited by TET1.
Finally, we observed a strong correlation between 5hmC distribution and chromatin 
accessibility, as judged by assay of transposase-accessible chromatin sequencing (ATAC-
seq)38 (Fig. 7). Although similar numbers of genomic regions gained and lost accessibility in 
Tet2-Tet3 DKO iNKT cells relative to their accessibility in wild-type cells (3,162 and 2,711, 
respectively), there was a marked overlap (37.5%) between differentially accessible regions 
(DARs) that lost accessibility in DKO iNKT cells and those that had 5hmC in wild-type 
iNKT cells (Fig. 7). In contrast, only a few regions (2.7%) that gained accessibility in Tet2-
Tet3 DKO iNKT cells relative to their accessibility in wild-type cells were marked by 5hmC 
in wild-type iNKT cells (Fig. 7a). A considerably smaller fraction of DARs than of DMRs 
were located close to TSS (Fig. 7b). Most DARs were located far from the TSS, whether 
they were less accessible in Tet2-Tet3 DKO iNKTs, more accessible in Tet2-Tet3 DKO 
iNKTs, or commonly accessible in both wild-type and Tet2-Tet3 DKO iNKTs. Overall, 
these data suggested a link between the loss of chromatin accessibility in Tet2-Tet3 DKO 
iNKT cells and the loss of 5hmC.
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Regulation of iNKT-cell-lineage-specifying factors
Tet2-Tet3 deficiency affected the chromatin accessibility and DNA-modification status of 
several genes encoding products involved in iNKT cell lineage specification and function 
(Supplementary Figs. 7 and 8). For example, a region near the TSS and first intron of Zbtb7b 
showed both a gain of 5mC+5hmC and a decrease in accessibility in Tet2-Tet3 DKO relative 
to such features in wild-type cells, Tet2-Tet3 DKO iNKT cells; note the large 
undermethylated canyon39 in the Zbtb7b proximal promoter that gains 5mC+5hmC at its 
edges (Supplementary Fig. 7a). Similarly, a region 5′ of the Tbx21 promoter that overlaps 
with a predicted thymic-specific enhancer34 showed a perceptible gain of 5mC+5hmC and 
there was a concomitant decrease in Tbx21 mRNA expression in young Tet2-Tet3 DKO 
relative to its expression in wild-type iNKT cells (Supplementary Fig. 7b). Moreover, an 
intragenic region in Tbx21 that overlaps a different predicted thymus-specific enhancer34 
showed lower accessibility in Tet2-Tet3 DKO iNKT cells than in wild-type iNKT cells 
(Supplementary Fig. 7b). Other genes encoding cytokines and transcriptional regulators, 
such as Il4, Ifng, Bcl11b and Satb1, also showed downregulated expression, parallel loss of 
chromatin accessibility and gain of DNA modification, and this was sometimes, but not 
always, at the same genomic sites (Supplementary Fig. 8 and data not shown). There were 
also examples in which a substantial increase in DNA modification was observed without a 
corresponding decrease in gene expression (for example, Gata3; data not shown). Overall, 
the data points to a stronger link between chromatin accessibility and 5hmC (measured by 
CMS-IP) than between chromatin accessibility and DNA modification (5mC+5hmC; 
measured by WGBS).
Notably, of the 3,162 regions that showed greater chromatin accessibility in Tet2-Tet3 DKO 
iNKT cells than in wild-type cells, eight were located in the vicinity of Rorc (Supplementary 
Fig. 7c), which correlated with higher expression of Rorc mRNA in Tet2-Tet3 DKO iNKT 
cells than in wild-type iNKT cells (Supplementary Fig. 7c). One of these more-accessible 
regions, located upstream of the Rorc promoter, overlapped a predicted thymic-specific 
enhancer34 (Supplementary Fig. 7c). Furthermore, motif-enrichment analysis of the 3,162 
DARs that were more accessible in Tet2-Tet3 DKO iNKT cells than in wild-type iNKT cells 
revealed considerable enrichment for the consensus RORγt-binding sequence (Fig. 7c); 
conversely, the 2,711 DARs that were less accessible in Tet2-Tet3 DKO iNKT cells than in 
wild-type iNKT cells showed enrichment for consensus binding sequences for T-box- and 
basic-region-leucine (bZIP) transcription factors (Fig. 7c). Overall, the skewing toward the 
NKT17 cell lineage that we observed in Tet2-Tet3 DKO iNKT cells might be explained by a 
combination of greater chromatin accessibility at the Rorc promoter and gene body and the 
enrichment for RORγt-binding motifs and loss of T-bet-binding motifs in Tet2-Tet3 DKO 
iNKT cells relative to such features in wild-type iNKT cells.
Suppression of aberrant RORγt expression by ThPOK and T-bet
Unlike Tbx21 (which encodes T-bet) and Zbtb7b (which encodes ThPOK), which both had 
high expression in wild-type iNKT cells and contained large amounts of 5hmC (Fig. 5b), 
Rorc had low expression and small amounts of 5hmC (Fig. 5b). T-bet and ThPOK probably 
both repress RORγt expression: T-bet deficiency redirects the development of iNKT cells 
toward the NKT2 and NKT17 cell lineages6,40, and decreased expression of ThPOK 
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correlates with increased NKT17 differentiation41. To confirm that ThPOK and T-bet were 
able to suppress the aberrant overexpression of RORγt in Tet2-Tet3 DKO iNKT cells, we 
retrovirally expressed these transcription factors in Tet2-Tet3 DKO iNKT cells. Indeed, 
ThPOK, in the absence of TET2 and TET3, was sufficient to completely suppress RORγt 
expression (Fig. 8a,b) and IL-17 production (Fig. 8c). T-bet, on the other hand, only partially 
suppressed RORγt expression in Tet2-Tet3 DKO iNKT cells (Fig. 8d,e). We concluded that 
the decrease in ThPOK and T-bet expression in Tet2-Tet3 DKO iNKT cells might explain 
the increase in RORγt expression.
DISCUSSION
We studied mice with disrupted Tet2 and Tet3 genes at the DP stage of thymocyte 
development. Tet2-Tet3 DKO mice showed a marked disease phenotype that reflected 
multiple factors: compromised development, migration and function of several T cell 
subsets; uncontrolled expansion of NKT17-cell-lineage-skewed iNKT cells; the appearance 
of innate CD8+ cells that did not migrate to the periphery; and a dysfunctional phenotype of 
Treg cells, with unstable Foxp3 expression resulting from impaired demethylation of the 
intronic Foxp3 enhancer CNS2 (ref. 27). For all these disease features, loss of function of 
the TET proteins was necessary; individual deletion of TET2 or TET3 had only mild effects.
The phenotype of iNKT cell expansion was already apparent in 3-week-old mice that had 
not yet developed the disease phenotype; it was recapitulated by the transfer of small 
numbers of highly purified Tet2-Tet3 DKO iNKT cells into immunocompetent recipient 
mice, which indicated that the expansion was not a result of the defect in functional Treg 
cells in Tet2-Tet3 DKO mice27. The expansion was antigen driven, as it was barely observed 
in CD1d-deficient recipient mice. Treg cells and iNKT cells were the two cell types most 
affected in Tet2-Tet3 DKO mice; a likely explanation is that conventional self-reactive T 
cells were deleted in the periphery, whereas both Treg cells and iNKT cells were ‘agonist 
selected’ and thus proliferated and survived42. The dominant iNKT cell phenotype might 
also reflect the highly proliferative nature of developing iNKT cells3. iNKT cell expansion is 
also common in mice lacking other epigenetic regulators, such as Ezh2 (ref. 43) and Jarid2 
(ref. 44), in T cells.
Notably, mice lacking individual TET proteins in T cells and hematopoietic stem cells show 
relatively mildly altered organismal phenotypes, such as individual germline deletions45. 
Deletions of Tet1 and Tet2 predispose mice to late-onset B cell malignancies and myeloid 
malignancies, respectively45. TET2 modulates cytokine production and gene expression in 
CD4+ helper T cells46 and partially controls Treg cell function27,47. However, inducible 
deletion of both Tet2 and Tet3 in mouse hematopoietic stem cells is needed to cause the 
rapid development of an aggressive acute myeloid leukemia35. One possible explanation for 
this is that TET1 and TET2 have distinct functions, whereas TET2 and TET3 have more 
redundant roles. Indeed, TET1 has a major role in the deposition of 5hmC at promoter and 
TSS regions in mouse embryonic stem cells, whereas TET2 (and, as shown here, TET3) 
seems to act predominantly at distal enhancers48. Because of the lack of commercially 
available chromatin-immunoprecipitation-quality antibodies, we were not able to pinpoint 
the genomic regions at which TET2 and TET3 act in T cells.
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Our genome-wide analyses provided a detailed view of the relationships among DNA-
modification status (5mC+5hmC, assessed by WGBS), 5hmC distribution (assessed by 
CMS-IP), chromatin accessibility (assessed by ATAC-seq) and gene expression in thymic 
iNKT cells. These factors are interconnected: several transcription factors and chromatin 
modifiers have been shown to recruit TET proteins45, and regions marked by 5hmC in wild-
type iNKT cells showed more chromatin accessibility than that of Tet2-Tet3 DKO iNKT 
cells. DMRs that lost or gained DNA modification (5mC+5hmC) during CLP–to–iNKT cell 
development also showed increased modification in Tet2-Tet3 DKO iNKT cells, which 
indicated that TET proteins participate in developmental transitions in lymphoid-lineage 
cells. Tbx21 and Zbtb7b, which encode the key transcriptional regulators T-bet and ThPOK, 
showed parallel decreases in 5hmC, chromatin accessibility and gene expression in Tet2-
Tet3 DKO iNKT cells relative to such features in wild-type iNKT cells, which indicated a 
requirement for TET2 and TET3. In contrast, the marked increase in accessibility and 
expression of Rorc and RORγt inTet2-Tet3 DKO iNKT cells appeared to be mediated 
indirectly through decreased expression of T-bet and ThPOK, as overexpression of either T-
bet or ThPOK in Tet2-Tet3 DKO iNKT cells suppressed RORγt expression. Future work 
will need to elucidate the precise sequence of molecular events that lead to TET-mediated 
control of iNKT cell expansion, lineage skewing and an acquisition of transmissible 
malignant phenotype.
ONLINE METHODS
Mice
Mice were housed in a pathogen-free animal facility at the La Jolla Institute for Allergy and 
Immunology and were used according to protocols approved by the Institutional Animal 
Care and Use Committee. Tet2−/− mice were generated by crossing CMVCre mice to 
Tet2fl/fl mice, in which exons 8, 9 and 10 that code for the catalytic HxD domain, were 
floxed (flanked by loxP sites)15. Tet3fl/fl mice were generated by targeting exon 2 (ref. 49). 
Tet2−/− and Tet3fl/fl mice were crossed with Cd4-Cre50 mice to generate Tet2−/−Tet3fl/fl Cd4-
Cre mice (DKO mice). These mice lack Tet3 in the T cell lineage due to deletion of Tet3 
exon 2 in thymocytes at the CD4+CD8+ (double-positive, DP) stage. The Tet2-Tet3 DKO 
mice are in the C57BL/6 background. B6.SJL-PtprcaPep3bBoyJ (CD45.1+) mice, C57BL/6 
(CD45.2+) mice and CD1dKO (Cd1dtg1.2) mice (B6(C)-Cd1d1tm1.2Aben/J) were 
purchased from Jackson laboratory. Both male and female mice were used in this study with 
similar findings. The majority of the experiments was done using young mice (3–5 weeks 
old as indicated). Analysis of older mice (6–8 weeks old) was performed to evaluate the 
lethal and aggressive nature of the observed phenotype. For transfer experiments 5–6 weeks 
old recipients were used. The recipients were of the same sex as the donors. Both male and 
female recipients were used and similar results were obtained.
Histology
Organs were isolated from age- and sex-matched control and Tet2-Tet3 DKO mice and 
placed immediately in 10% formalin (Fisher), fixed overnight and then placed in 70% 
ethanol. Samples were paraffin-embedded, sectioned, stained with haematoxylin and eosin, 
and imaged using a Nikon Eclipse 80i microscope.
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Flow Cytometry
Cells were isolated from thymus, spleen, lymph nodes and bone marrow. Surface staining 
was performed using antibodies from BioLegend: CD4 (RM4-5), CD8 (53-6.7), TCRβ 
(H57-597), B220 (RA3-6B2), CD44 (IM7), CD122 (5H4), CD24 (M1/69), CXCR3 
(CXCR3-173), CD45.1 (A20), CD45.2 (104), CCR6 (29-2L17), CD103 (2E7), IL-4 
(11B11), IL-17-F (9D3.1C8) and eBioscience: Eomes (Dan11mag), CD27 (LG-7F9) and 
IFN-γ (XMG1.2). PLZF (R17-809), T-bet (O4-46) and RORγt (Q31-378) were purchased 
from BD Pharmingen. In the initial stages of this study PLZF-Alexa Fluor 647 (D-9) was 
used and was obtained from Santa Cruz. α-GalCer–CD1d tetramer (conjugated either with 
PE or with BV421) was obtained from the NIH Tetramer Core. Vα14 iNKT cells were 
routinely defined as TCRβ intermediate, B220− and positive for α-GalCer–CD1d tetramer 
binding. Intracellular staining for transcription factors PLZF, RORγt and Eomes was 
performed using the Foxp3 staining kit (cat no: 00-5523-00) from eBioscience. In order to 
evaluate the simultaneous expression of PLZF and T-bet in iNKT cell subsets a different 
staining strategy was followed that in our hands significantly increased the efficiency of T-
bet staining51. Briefly, cells were surfaced stained, washed in flow cytometry staining buffer 
(PBS containing 3% FBS), resuspended in 100 μl PBS and then add 100 μl of 4% methanol-
free formaldehyde (Pierce) to obtain a final concentration of 2% formaldehyde. Cells were 
fixed for 30 min, centrifuged and washed in 200 μl of 1× permeabilization buffer from the 
Foxp3 staining kit (cat no: 00-5523-00) from eBioscience. Subsequently, the cells were 
resuspended in 1x Permeabilization buffer (Foxp3 staining kit) containing PLZF-A647 
(R17-809) and T-bet (O4-46) Alexa Fluor 488 and RORγt (Q31-378) PE CF594. 
Acquisition was performed in a BD LSR Fortessa (BD Biosciences) using the BD 
FACSDiva Software. Data analysis was performed with FlowJo (Treestar).
Ex vivo cytokine production
Thymocytes (in a concentration of 1 × 106 cells/ml) were stimulated in the presence of 50 
ng/ml PMA and 1.5 μM ionomycin for 4 h. In the last 2 h of culture Brefeldin A was added 
in a concentration of 10 μg/ml. Cells were washed, stained for surface markers and fixed 
with 2% of formaldehyde for 15 min at 37 °C. Subsequently the protocol of the transcription 
factor staining set from BD was followed to stain for IL-4 (11B11), IL17-F (9D3.1C8) and 
IFN-γ (XMG1.2).
In vivo BrdU incorporation
Mice were intraperitoneally injected with 100 μl of 10 mg/ml BrdU. 16 h later mice were 
euthanized and the cells were stained for surface markers and subsequently for BrdU 
according to the accompanying protocol (BD Pharmingen, APC BrdU flow kit 552598).
Isolation of Vα14 iNKT cells
Vα14 iNKT cell preparations for RNASeq analysis, CMS-IP seq and WGBS seq were 
performed using in case of control mice a pool of cells (isolated from thymus or spleen as 
indicated on each case) from C57BL/6 mice and from age- and sex-matched Tet2-Tet3 DKO 
mice. For fluorescence-activated cell sorting (FACS), cells from wild-type mice were 
depleted of CD19+ (6D5), TER-119+ (TER119), CD8+ (53-6.7), CD11c+ (N418), F4/80+ 
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(BM8) and CD11b+ (M1/70) cells using biotinylated antibodies (BioLegend) and subsequent 
binding to magnetic streptavidin beads (Life Technologies). The unbound cells were 
incubated with 1 μg/ml Streptavidin A (Sigma-Aldrich) and subsequently stained with α-
GalCer-loaded Cd1d tetramers and anti-TCRβ, after which tetramer-binding, TCRβ+ cells 
were isolated using a FACSAria cell sorter (BD Biosciences). To obtain Tet2-Tet3 DKO 
cells, no depletion was performed since iNKT cells had proliferated extensively. Rather, live 
B220− α-GalCer-Cd1d tetramer-binding, TCRβ+ cells were isolated using a FACSAria cell 
sorter (BD Biosciences).
Transduction of Vα14 Tet2-Tet3 DKO iNKT cells
3 × 106 PLAT-E cells were seeded in 10-cm plates. The cells were cultured in DMEM 
(Invitrogen) containing 10% FBS and in the absence of antibiotics. Retrovirus was produced 
by transfecting PLAT-E cells with pRV T-bet52 or pMX-ThPOK-IRES-GFP. The Mirus 
transfection reagent was used according to the manufacturer’s guidelines. We collected the 
supernatants 48 h and 72 h post-transfection and stored them at 4 °C. iNKT cells were sorted 
from Tet2-Tet3 DKO mice 3–4 week-old and cultured in the presence of 10 ng/ml IL-7. 24 h 
and 48 h post sorting iNKT cells were infected by addition of virus in the presence of 10 
μg/mL polybrene and centrifuged at 931 g for 90 min at 35 °C. 24 h after the second 
transduction Tet2-Tet3 DKO iNKT cells were sorted based on GFP expression to separate 
un-transduced from transduced cells. To monitor if ThPOK and T-bet could bypass the loss 
of TET2 and TET3 and directly regulate RORγt expression and subsequent IL-17 secretion, 
GFP− (non-transduced) and GFP+ (transduced) cells were compared by flow cytometry for 
RORγt expression. Cells were rested post sorting and restimulated in the presence of 10 nM 
of PMA and 1nM ionomycin for 4 h. 5 μg/ml brefeldin A (Sigma) was added for the last 2 h 
to inhibit cytokine secretion.
Splenocyte and iNKT cell adoptive transfer
Total splenocytes or sorted iNKT cells were transferred retro-orbitrally to non-irradiated, 
fully immune-competent congenic (B6.SJL-PtprcaPep3bBoyJ) (CD45.1+) mice. The mice 
were monitored by bleeding and subsequent flow cytometry analysis to evaluate the 
proliferation of the transferred cells.
Bulk RNA-seq
Total RNA was isolated from thymic iNKT cells isolated from young (3–4 weeks old) mice 
and spleens from wild type or congenic recipients of Tet2-Tet3 DKO iNKT cells using the 
E.Z.N.A. HP Total RNA kit (Omega) according to the manufacturer’s instructions. Libraries 
were prepared using the Truseq RNA stranded kit (Illumina). The starting RNA material was 
1 μg. Briefly, polyA+ RNAs were selected with magnetic beads, the RNA was fragmented 
and cDNA was synthesized. After A-tailing and adaptor ligation, libraries were generated by 
amplifying the cDNA for 10–12 cycles. 3 different biological replicates per genotype were 
evaluated. The results of these experiments are shown in Figures 3a and 4d–f.
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Micro-scaled RNA-seq (Smart-seq) of total iNKT cells
In this case, the starting total RNA for each library was 10 ng. RNA was isolated from wild-
type, Tet3 KO and Tet2-Tet3 DKO iNKT cells (data depicted in Fig. 3b) we performed 
SMART-seq as previously described53. RNA was isolated using the RNeasy Micro kit 
(Qiagen). RNA was incubated with free dNTPs and tailed oligo-dT oligonucleotides. The 
reverse transcription reaction was performed at 42 °C in the presence of 1 M betaine 
(Sigma) and increased concentration of MgCl2 (6 mM) to increase cDNA yield. SuperScript 
II reverse transcriptase and RNAse Out Inhibitor (Invitrogen) were used. Template switching 
oligonucleotides (TSO) were added to enable template switching by the reverse 
transcriptase, which synthesizes a complementary sequence to the TSO. Nine cycles of pre-
amplification were performed using the KAPA HiFi HotStart Ready Mix (Kapa 
Biosystems). PCR products were purified with Ampure XP beads (Beckman Coulter) and 
quantified using High Sensitivity DNA Qubit (Life Technologies). The size distribution of 
the amplified DNA was evaluated in a high-sensitivity Bioanalyzer DNA chip (Agilent). 
Following the pre-amplification step, cDNA was tagmented using Nextera XT DNA kit 
(Illumina). 1 ng of cDNA per tagmentation reaction was used. The reaction was performed 
at 55 °C for 5 min. The Tn5 tranposase was stripped off the tagmented DNA by adding 
neutralize tagment (NT) buffer according to the manufacturers. Eight cycles were performed 
for amplification of adaptor-ligated fragments using the Nextera PCR master mix and 
selected indexed primers (Nextera XT Index kit, Illumina). Two independent SMARTseq 
samples per genotype were used.
Micro-scaled RNA-seq (Smart-seq) of iNKT cell subsets
To prepare the SMART-seq samples for the wild-type and the Tet2-Tet3 DKO subsets iNKT 
cell stage 1 (defined as TCRint tetramer+ CD24−NK1.1+CD27+CCR6−) (n = 2 subsets 
isolated from two different mice/genotype were assessed) and the TCRint tetramer+ 
CD24−NK1.1− (containing mainly stage II iNKT cells) (n = 3 subsets isolated from three 
independent mice per genotype were evaluated). For the library preparation, ten cycles of 
PCR amplification were used. The data are shown in Figure 3c.
In all cases, the integrity of the isolated RNA was evaluated in the Bioanalyzer (Agilent 
Technologies). Only samples with a minimum RIN value of 9 were used for library 
preparation. The quality and quantity of the amplified libraries was evaluated using 
Bioanalyzer (Agilent Technologies Inc) and HS Qubit (Life Technologies). The libraries 
were pooled in a concentration of 10 nM and sequenced using an Illumina Hiseq 2500 
instrument.
Genome-wide 5hmC mapping by CMS-IP-seq
Vα14 iNKT cells were isolated by flow cytometry and DNA was isolated using the PureLink 
genomic DNA mini kit (Life Technologies). DNA was fragmented to an average size of 200 
bp using the Adaptive Focused Acoustics Covaris S2 instrument. Library preparation, 
bisulfite treatment and immunoprecipitation of CMS (5hmC)-enriched DNA were performed 
as previously described13,31. Briefly, fully unmethylated λ (lambda) DNA (Promega) was 
spiked into the mouse genomic DNA at a ratio of 1:200. DNA was end-repaired using the 
End Repair (Illumina Epicentre) and A-tailed (using Klenow fragment, New England 
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BioLabs). Ligation of methylated adapters (NeBNext Multiplex Oligos for Illumina, New 
England BioLabs) was performed using Quick Ligase Kit (New England BioLabs). DNA 
was bisulfite-treated using the MethylCode Bisulfite Conversion Kit (Life Technologies). 
1% of bisulfite-converted DNA was kept as input and the rest was used for 
immunoprecipitation with anti-CMS antibody31. The anti-CMS recognizes 5hmC that upon 
bisulfite treatment is converted to cytosine-5-methylenesulfonate (CMS), enabling thus the 
enrichment of 5hmC containing DNA fragments31. The immunoprecipitated DNA was 
amplified using Kapa HiFi Uracil+ (Kapa Biosystems). Two different CMS-IP samples per 
genotype were evaluated.
Whole-genome bisulfite sequencing (WGBS-seq)
Vα14 iNKT cells were isolated by flow cytometry and DNA was isolated using the PureLink 
genomic DNA mini kit (Life technologies). DNA was fragmented. 1.5 μg of the fragmented 
DNA was used for the library preparation and bisulfite treatment was done as described in 
the CMS-IP seq section. After the bisulfite conversion the purified DNA was amplified for 4 
cycles (low amplification) using Kapa HiFi Uracil+ (Kapa Biosystems). 2 independent 
WGBS samples per genotype were evaluated.
In describing the WGBS data, we use the term “DNA modification” (5mC+5hmC) in 
preference to “DNA methylation” because bisulfite sequencing does not distinguish between 
5mC and 5hmC54, and because dot blot analysis shows persisting 5hmC in Tet2-Tet3 DKO 
thymocytes (Supplementary Fig. 1b) that is most likely deposited by TET1 (Supplementary 
Fig. 1a). However, the term “DNA methylation” is approximately correct, since 5hmC 
represents only a small percentage of total modified cytosines in T cells (<10% of 
5mC)14,55.
To examine changes in DNA modification at the level of individual TSS regions and gene 
bodies, we calculated the average change in DNA modification in each gene body and at 
each promoter/TSS region (DMR discovery; Supplementary Methods), and plotted the 
values against the change in expression of the corresponding gene (Supplementary Fig. 6b).
Identifying chromatin accessibility by the assay of transposase-accessible chromatin 
sequencing (ATAC-seq)
Libraries were prepared as previously described38. 5 × 104 iNKT cells were sorted, washed 
once with PBS and lysed in 100 μl of ice-cold lysis buffer (10 mM Tris-HCl, pH 7.4, 10 mM 
NaCl, 3 mM MgCl2 and 0.1% IGEPAL CA-630). Then, nuclei were spun at 500g for 10 min 
and the pellet was resuspended in 50 μl transposase reaction mix [2.5 μl transposase 
(Illumina), 25 μl 2 × TD buffer (Illumina) and 22.5 μl nuclease free water). The reaction was 
incubated for 30 min at 37 °C. Samples were purified using MinElute kit (Qiagen). The 
purified DNA was amplified using Kapa Real time library amplification kit (Kapa 
Biosystems). Libraries were amplified for 10–11 cycles. iNKT cells isolated from 3 different 
mice/genotype were evaluated.
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Quantitative real-time RT PCR
Total RNA from DP, CD4SP and CD8SP T cells was isolated with E.Z.N.A HP Total RNA. 
cDNA was synthesized using Superscript reverse transcriptase and oligo(dT) primers (Life 
Techologies), and gene expression was evaluated with Step One Plus (Applied Biosystems) 
using Roche SYBR green real-time master. The following primers were used: Tet1F: 5′-
GAGCCTGTTCCTCGATGTGG-3′, Tet1R: 5′-CAAACCCACCTGAGGCTGTT-3′, Tet2F: 
5′-AACCTGGCTACTGTCATTGCTCCA-3′, Tet2R: 5′-
ATGTTCTGCTGGTCTCTGTGGGAA-3′; Tet3F: 5′-GTCT 
CCCCAGTCCTACCTCCG-3′, Tet3R: 5′-GTCAGTGCCCCACGCTTCA-3′
Analysis of CMS (bisulfite-converted 5hmC) abundance by dot blot
100 ng genomic DNA samples were sheared using needle and treated with sodium bisulfite 
using the Methylcode bisulfite kit (Invitrogen). DNA was prepared using twofold serial 
dilutions in TE buffer and then denatured in 0.4 M NaOH, 10mM EDTA at 95 °C for 10 min 
and followed by adding an equal volume of cold 2M ammonium acetate (pH 7.0) on ice for 
10 min. Denatured DNA samples were spotted on a nitrocellulose membrane in an 
assembled Bio-Dot apparatus (Bio-Rad) according to the manufacturer’s instructions. The 
membrane was washed with 2 × SSC buffer and then vacuum-baked at 80 °C for 2 h. Then 
the membrane was blocked with 5% non-fat milk for 1 h and incubated with rabbit antisera 
against CMS detected by HRP conjugated secondary antibody and enhanced 
chemiluminescence.
Statistical Analysis
Statistical analysis was performed with GraphPAd Prism6 (Graphpad software). Unpaired t 
test, Log-rank (Mantel-Cox) test and Gehan-Brenslow-Wilcoxon test were applied as 
indicated and the P-values are shown for each figure. Data are mean ± s.e.m. If not 
otherwise indicated the P value was not statistically significant (P > 0.05). In the graphs each 
dot represents a mouse. For all the experiments we used sufficient number of mice to ensure 
adequate power for our conclusions. Mice from different litters and of different sex were 
evaluated. In addition, we ensured that a minimum of 2 independent experiments was 
performed in each case. No blinding was applied in this study.
Data availability
Data that support the findings of this study have been deposited in GEO with the accession 
code GSE66834. Source data for Figures 3–7 are provided with the paper.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Simultaneous deletion of Tet2 and Tet3 severely compromises T cell homeostasis, leading to 
iNKT cell expansion and disease. (a) Quantification of total cells in the spleen of 5- to 7-
week-old wild-type mice (WT) (n = 5) and Tet2-Tet3 DKO mice (DKO) (n = 6). (b) 
Disease-free survival of wild-type mice (n = 10) and Tet2-Tet3 DKO mice (n = 10) (Kaplan-
Meier curve). (c) iNKT cells in spleens of 4-week-old wild-type (n = 6) versus Tet2-Tet3 
DKO (n = 3) mice. (d) Quantification (left) and frequency (right) of iNKT cells in spleens 
isolated from 4-week-old Tet2-Tet3 DKO mice (n = 3) and wild-type mice (n = 6). (e) iNKT 
cells in the spleen of 3- to 4-week-old wild-type mice (n = 5), Tet2−/− (Tet2 KO) mice (n = 
3), Tet3 KO mice (n = 3) and Tet2-Tet3 DKO mice (n = 6). (f) Frequency of iNKT cells in 
wild-type mice (n = 5), Tet2 KO mice (n = 3), Tet3 KO mice (n = 4) and Tet2-Tet3 DKO 
mice (n = 6) (left), and number of iNKT cells in wild-type mice (n = 3), Tet2 KO mice (n = 
3), Tet3 KO mice (n = 3) and Tet2-Tet3 DKO mice (n = 6) (right). Numbers adjacent to 
outlined areas (c,e) indicate percent tetrameter+TCRβ+ cells. Each symbol (a,d,f) represents 
an individual mouse; horizontal lines indicate the mean (± s.e.m.). *P < 0.05, **P < 0.01, 
***P < 0.001 and ****P < 0.0001 (unpaired t-test). Data are representative of 5 experiments 
(a), 10 experiments (b), 3 experiments (d), 3 experiments (e) or 3 experiments (f) or are 
from three independent experiments (c).
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Figure 2. 
Tet2-Tet3 DKO iNKT cells in the thymus of young (3- to 4-week-old) mice are skewed 
toward the NKT17 cell lineage. (a) iNKT cells in the thymus of 20-day-old wild-type and 
Tet2-Tet3 DKO mice. Numbers adjacent to outlined areas indicate percent tetrameter
+TCRβ+ cells. (b,c) Frequency (b) and number (c) of iNKT cells in the thymus of Tet2-Tet3 
DKO mice (n = 22) and wild-type mice (n = 15). (d) Flow cytometry analysis of the 
expression of PLZF and RORγt in tetramer+CD24−TCRβ+ thymocytes. (d,e) Flow 
cytometry analysis of the expression of PLZF and RORγt (d) or of PLZF and T-bet (e) in 
tetramer+CD24−TCRβ+ thymocytes. (f) Frequency of iNKT cell subsets among total iNKT 
cells. (g) Results in f, presented as frequency among total thymocytes. (h) Flow cytometry of 
tetramer+CD24−TCRβ+ thymocytes from wild-type mice (n = 9) (top) and Tet2-Tet3 DKO 
mice (n = 12) (bottom), analyzing the expression of NK1.1 and binding of tetramer (left), 
expression of CD4 and CD27 in the tetramer+NK1.1− subset (arrow) (middle), and 
expression of CCR6 and CD27 in the tetramer+NK1.1+ subset (arrow) (right). (i) Frequency 
of the NK1.1− and NK1.1+ subsets (as defined in h) among total iNKT cells. (j) 
Quantification of the NK1.1− and NK1.1+ subsets (as defined in h) among total iNKT cells. 
Numbers adjacent to outlined areas (a,d,e,h) indicate percent cells in each. Each symbol 
(b,c,f,g,i,j) represents an individual mouse; horizontal lines indicate the mean (± s.e.m.). *P 
< 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (unpaired t-test). Data are 
representative of 15 experiments (a), 5 experiments (i), 5 experiments (i), are from one 
experiment representative of four experiments (b–e) or are from four independent 
experiments with five wild-type mice and seven Tet2-Tet3 DKO mice (f,g) or five 
independent experiments (h).
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Figure 3. 
Gene-expression profiles of thymic wild-type and Tet2-Tet3 DKO iNKT cells. (a) Mean 
average (MA) plot of genes expressed differentially in thymic iNKT cells isolated from 
Tet2-Tet3 DKO relative to their expression in such cells from wild-type mice. (b) Expression 
of genes encoding selected transcriptional regulators (left) and cytokines and their receptors 
(right) in Tet2-Tet3 DKO, Tet3 KO and wild-type thymic iNKT cells, presented as row-wise 
z-scores (red, higher expression, and blue, lower expression, relative to other conditions). (c) 
Expression of selected genes of interest in stage 0, NK1.1− and NKT1 iNKT subsets. (d) 
Flow cytometry analysis of BrdU incorporation in tetramer+TCRβ+ thymocytes. Numbers 
adjacent to outlined areas indicate percent cells with BrdU incorporation. (e) Frequency of 
tetramer+TCRβ+ iNKT cells that incorporated BrdU. Each symbol represents an individual 
mouse; horizontal lines indicate the mean (± s.e.m.). **P < 0.01, (unpaired t test). Data are 
representative of one experiment with three biological replicates per genotype (a), one 
experiment with two biological replicates per genotype (b), one experiment with two 
biological replicates per genotype for stage 0, three biological replicates per genotype for 
NK1.1−, two biological replicates wild-type NKT1, and three biological replicates per 
genotype for DKO NKT1 (c), are from one experiment representative of two experiments 
with five mice per genotype (d) or from two independent experiments with five mice per 
genotype (e).
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Figure 4. 
Antigen stimulation promotes the expansion of Tet2-Tet3 DKO iNKT cells and disease 
development in fully immunocompetent recipients. (a) Disease-free survival of wild-type (n 
= 6) and CD1dKO recipients (n = 5) of Tet2-Tet3 DKO iNKT cells (Kaplan-Meier curve). 
**P < 0.01 (log-rank (Mantel-Cox) test and Gehan-Brenslow-Wilcoxon test). (b) Cellularity 
of the spleen (left) and lymph nodes (right) of wild-type recipients (n = 12) and CD1dKO 
recipients (n = 6) of Tet2-Tet3 DKO iNKT cells. (c) Frequency (top) and numbers (bottom) 
of iNKT cells in the spleen of wild-type recipients (n = 12) and CD1dKO recipients (n = 6) 
of Tet2-Tet3 DKO iNKT cells. (d) MA plot of genes expressed differentially in transferred 
and expanded Tet2-Tet3 DKO iNKT cells isolated from the spleen of congenic recipient 
mice relative to their expression in iNKT cells isolated from the spleen of healthy wild-type 
mice. (e) Expression (log2 fold values) of selected genes encoding transcriptional regulators 
with differential expression (higher (red) or lower (blue)) in Tet2-Tet3 DKO iNKT cells than 
in wild-type iNKT cells. (f) Pathway-enrichment analysis of differentially expressed genes 
in transferred Tet2-Tet3 DKO iNKT cells: purple, categories related to DNA replication, cell 
cycle and DNA repair; green, categories related to T cell function. Each symbol (b,c) 
represents an individual mouse; horizontal lines indicate the mean (± s.e.m.). **P < 0.01, 
***P < 0.001 (unpaired t test). Data are from two independent experiments (a), three 
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independent experiments (b,c), or one experiment with three biological replicates per 
genotype (d–f).
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Figure 5. 
5hmC shows enrichment in the bodies of genes with high expression in iNKT cells and 
those expressing key iNKT-cell-lineage-specifying factors. (a) CMS-IP analysis of the 
enrichment for 5hmC over the gene body, categorized on the basis of gene expression (RNA-
seq analysis), in wild-type thymic iNKT cells. (b) Genome browser views of intragenic 
5hmC (CMS-IP analysis) and gene expression (RNA-seq analysis) in Tbx21, Zbtb7b and 
Rorc in wild-type thymocytes. (c) Average enrichment for 5mC+5hmC over the gene body, 
categorized on the basis of gene expression (WGBS and RNA-seq analysis), in wild-type 
thymic iNKT cells. (d) Average enrichment of 5hmC in wild-type iNKT cells from tissue-
specific enhancers in the thymus (orange), mouse embryonic stem cells (mESC; blue) and 
heart (green)34. (e) Modification of 5mC+5hmC in wild-type and Tet2-Tet3 DKO iNKT 
cells, plotted against position relative to DMR. Data are representative of one experiment 
with two biological replicates for CMS-IP seq, two biological replicates for WGBS and 
three biological replicates for RNA-seq.
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Figure 6. 
TET proteins regulate DNA modification in iNKT cells. (a) DNA modification in CLPs and 
wild-type and Tet2-Tet3 DKO iNKT cells, showing more (red) or less (blue) modification. 
(b) RNA-seq analysis of Tet1, Tet2 and Tet3 in iNKT cells and CLPs. (c) Quantification of 
DMRs relative to their distance to the TSS. Data are representative of one experiment with 
two technical replicates for CLPs and two biological replicates per genotype for iNKT cells 
(a,c), and three biological replicates for iNKT cells and one sample for CLPs (b).
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Figure 7. 
Characterization of chromatin regions with differential accessibility in wild-type iNKT cells 
versus Tet2-Tet3 DKO iNKT cells. (a) ATAC-seq analysis of DARs (red) in wild-type iNKT 
cells versus Tet2-Tet3 DKO iNKT cells: black, DARs that overlap 5hmC (CMS-IP peaks). 
(c) Motif-enrichment analysis (HOMER) of the 3,162 DARs more accessible in Tet2-Tet3 
DKO iNKT cells than in wild-type iNKT cells (top) and of the 2,711 DARs less accessible 
in Tet2-Tet3 DKO iNKT cells than in wild-type cells (bottom). (b) Distance of DARs to the 
nearest TSS, among DARs less (blue) or more (red) accessible in Tet2-Tet3 DKO iNKT cells 
than in wild-type iNKT cells or commonly accessible in both wild-type and Tet2-Tet3 DKO 
iNKT cells (gray). Data are representative of two experiments and three biological replicates 
per genotype in total for ATAC seq. For CMS-IP, data are representative of one experiment 
with two biological replicates.
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Figure 8. 
Ectopic expression of ThPOK or T-bet in Tet2-Tet3 DKO iNKT cells can suppress the 
aberrant increase in RORγt expression. (a) Flow cytometry analysis of RORγt expression in 
Tet2-Tet3 DKO iNKT cells transduced to express ThPOK (ThPOK+) or not (ThPOK−). (b) 
Frequency of RORγt-expressing Tet2-Tet3 DKO iNKT cells as in a. (c) Flow cytometry 
analysis of Rorγt expression and IL-17F production in Tet2-Tet3 DKO iNKT cells as in a. 
(d) Flow cytometry analysis of RORγt expression in Tet2-Tet3 DKO iNKT cells transduced 
to express T-bet (T-bet+) or not (T-bet−). (e) Frequency of RORγt-expressing Tet2-Tet3 
DKO iNKT cells as in d. Each symbol (b,e) represents an individual mouse; horizontal lines 
indicate the mean (± s.e.m.). *P < 0.05, ****P < 0.0001 (unpaired t test). Data are 
representative of four experiments (a) or three experiments (d) or are from four independent 
experiments with a total of five mice (b), one experiment representative of two experiments 
with three mice (c) or one experiment representative of three experiments (e).
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Table 1
DMRS (5mC+5hmC) identified by WGBS of wild-type and Tet2-Tet3 DKO i NKT cells
DMRs
DMRs more methylated in Tet2-Tet3 
DKO versus WT iNKT cells
DMRs less methylated in Tet2-Tet3 
DKO versus WT iNKT cells
Total DMRs 10,945 767
DMRs overlapping WT CMS-IP 4,568 10
DMRs overlapping WT CMS-IP close to promoters 
(±5 kb)
1,468 5
Unique genes from above 1,270 4
Downregulated 138 0
Upregulated 45 3
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